BackTyra Biosciences Overview

Tyra Biosciences Receivables

Track Tyra Biosciences's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
100.00% YoYΔ $-1.70M vs prior year quarter

Peer trimmed avg / median

Loading

Tyra Biosciences Receivables History

Loading

Tyra Biosciences vs. peers: Receivables Comparison

Loading

Tyra Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tyra Biosciences (TYRA) FAQ

As of the most recent data (June 2026), TYRA shows a receivables of $0. That compares with $1.7M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TYRA's receivables is now $0 (was $1.7M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Tyra Biosciences is outperforming or lagging.

Tracking TYRA's receivables over time shows whether Tyra Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.7M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Tyra Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Tyra Biosciences's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.